These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12623758)

  • 1. Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases.
    Timperio AM; Kuiper HA; Zolla L
    Xenobiotica; 2003 Feb; 33(2):153-67. PubMed ID: 12623758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone.
    Hoogenboom LA; Tomassini O; Oorsprong MB; Kuiper HA
    Food Chem Toxicol; 1991 Mar; 29(3):185-91. PubMed ID: 2032659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detection.
    Hoogenboom LA; van Kammen M; Berghmans MC; Koeman JH; Kuiper HA
    Food Chem Toxicol; 1991 May; 29(5):321-8. PubMed ID: 2060890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of furaltadone by pig hepatocytes and Salmonella typhimurium TA 100 bacteria, and the formation of protein-bound metabolites.
    Hoogenboom LA; Polman TH; Lommen A; Huveneers MB; van Rhijn J
    Xenobiotica; 1994 Aug; 24(8):713-27. PubMed ID: 7839695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinations of residual furazolidone and its metabolite, 3-amino-2-oxazolidinone (AOZ), in fish feeds by HPLC-UV and LC-MS/MS, respectively.
    Hu XZ; Xu Y; Yediler A
    J Agric Food Chem; 2007 Feb; 55(4):1144-9. PubMed ID: 17300147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of a mutagenic metabolite released from protein-bound residues of furazolidone.
    Hoogenboom LA; van Bruchem GD; Sonne K; Enninga IC; van Rhijn JA; Heskamp H; Huveneers-Oorsprong MB; van der Hoeven JC; Kuiper HA
    Environ Toxicol Pharmacol; 2002 Jul; 11(3-4):273-87. PubMed ID: 21782611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the residues of furazolidone and its metabolite, 3-amino-2-oxazolidinone (AOZ), in eggs.
    McCracken RJ; Spence DE; Floyd SD; Kennedy DG
    Food Addit Contam; 2001 Nov; 18(11):954-9. PubMed ID: 11665736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an indirect competitive ELISA for the detection of furazolidone marker residue in animal edible tissues.
    Chang C; Peng DP; Wu JE; Wang YL; Yuan ZH
    J Agric Food Chem; 2008 Mar; 56(5):1525-31. PubMed ID: 18260630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and possible causes of bound and extractable residues of the furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues.
    McCracken RJ; McCoy MA; Kennedy DG
    Food Addit Contam; 1997 Apr; 14(3):287-94. PubMed ID: 9135726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioavailability of residues of the furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues and the effect of cooking upon residue concentrations.
    McCracken RJ; Kennedy DG
    Food Addit Contam; 1997 Jul; 14(5):507-13. PubMed ID: 9328536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of active oxygen species in protein and oligonucleotide degradation induced by nitrofurans.
    Zolla L; Timperio AM
    Biochem Cell Biol; 2005 Apr; 83(2):166-75. PubMed ID: 15864325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by furazolidone in germfree rats.
    Yeung TC; Goldman P
    Biochem Pharmacol; 1981 Sep; 30(17):2496-7. PubMed ID: 21043255
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of 3-amino-2-oxazolidinone (AOZ), a tissue-bound metabolite of the nitrofuran furazolidone, in prawn tissue by enzyme immunoassay.
    Cooper KM; Elliott CT; Kennedy DG
    Food Addit Contam; 2004 Sep; 21(9):841-8. PubMed ID: 15666977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side-chain from liver, kidney and muscle tissues from pigs.
    Hoogenboom LA; Berghmans MC; Polman TH; Parker R; Shaw IC
    Food Addit Contam; 1992; 9(6):623-30. PubMed ID: 1302201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
    Planz G; Quiring K; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):27-42. PubMed ID: 4260803
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the furazolidone metabolite, 3-amino-2-oxazolidinone, in porcine tissues using liquid chromatography-thermospray mass spectrometry and the occurrence of residues in pigs produced in Northern Ireland.
    McCracken RJ; Kennedy DG
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):87-94. PubMed ID: 9140761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue depletion and concentration correlations between edible tissues and biological fluids of 3-amino-2-oxazolidinone in pigs fed with a furazolidone-medicated feed.
    Liu Y; Huang L; Wang Y; Yang B; Ishan A; Fang K; Peng D; Liu Z; Dai M; Yuan Z
    J Agric Food Chem; 2010 Jun; 58(11):6774-9. PubMed ID: 20443624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated treatment with furazolidone induces multiple cytochrome p450-related activities in chicken liver, but not in rat liver.
    Sasaki N; Matumoto T; Ikenaka Y; Nakayama SM; Ishizuka M; Kazusaka A; Fujita S
    J Vet Med Sci; 2013 Nov; 75(11):1497-502. PubMed ID: 23774039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of protein-bound metabolites of furazolidone and furaltadone in pig liver by high-performance liquid chromatography and liquid chromatography-mass spectrometry.
    Horne E; Cadogan A; O'Keeffe M; Hoogenboom LA
    Analyst; 1996 Oct; 121(10):1463-8. PubMed ID: 8918218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-monoamine oxidase effects of furazolidone.
    Stern IJ; Hollifield RD; Wilk S; Buzard JA
    J Pharmacol Exp Ther; 1967 Jun; 156(3):492-9. PubMed ID: 6028876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.